FB2026_02 , released June 18, 2026
Human Disease Model Report: Charcot-Marie-Tooth disease, dominant intermediate B
Open Close
General Information
Name
Charcot-Marie-Tooth disease, dominant intermediate B
FlyBase ID
FBhh0000973
Overview

This report describes DNM2-implicated subtypes of Charcot-Marie-Tooth disease (the two subtypes are described in one entry in OMIM): Charcot-Marie-Tooth disease, dominant intermediate B (CMTDIB or DI-CMTB) and Charcot-Marie-Tooth disease, axonal type 2M (CMT2M). The human gene implicated, Dynamin 2 (DNM2) encodes a large force-producing GTPase associated with microtubules and involved in endocytosis and intracellular membrane trafficking. DNM2 is implicated in multiple other diseases, including a form of centronuclear myopathy (see MIM:602378). There is a single fly ortholog, Dmel\shi, for which classical loss-of-function alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated. Dmel\shi is also the highest scoring ortholog for two additional human dynamins, DNM1 and DNM3.

Multiple different UAS constructs of the human Hsap\DNM2 gene have been introduced into flies, including wild-type DNM2 and genes carrying mutational lesions implicated in Charcot-Marie-Tooth disease and centronuclear myopathy (CNM1). Animals carrying mutant alleles of Hsap\DNM2 exhibit reduced viability, locomotor behavior defective phenotypes, muscle fiber atrophy, and exhibit cellular abnormalities in larval muscles.

Variant(s) implicated in human disease tested (as transgenic human gene, DNM2): the variant form G537C has been introduced into flies. Variants implicated in CNM1 (FBhh0000093) have also been tested in flies.

Loss-of-function mutations in the Dmel\shi gene are lethal; multiple temperature-sensitive alleles have been isolated. A UAS-heat-sensitive allele produces neuroanatomy defective, behavior defective, paralytic, chemical resistant and other phenotypes, depending upon the GAL4 driver used. Genetic and physical interactions of Dmel\shi have been described; see below and in the shi gene report.

[updated Feb. 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: Charcot-Marie-Tooth disease
Symptoms and phenotype

Charcot-Marie-Tooth disease (CMT) constitutes a clinically and genetically heterogeneous group of hereditary motor and sensory peripheral neuropathies. CMT is divided into several major types: Type 1 is characterized by demyelination and by a significantly slowed motor median nerve conduction velocity (NCV). Type 2 is characterized by axonal abnormalities and a normal or slightly reduced NCV. "Intermediate" types describe CMT families with nerve conduction velocities, in different affected individuals, that overlap the division between Type 1 and Type 2. Additional types are defined on the basis inheritance patterns. [from MIM:609260 and MIM:606482; 2015.12.15]

Symptoms typically include progressive distal muscle weakness and atrophy, often associated with mild to moderate sensory loss, depressed tendon reflexes, and high-arched feet. [from Gene Reviews, http://www.ncbi.nlm.nih.gov/books/NBK1358 2015.12.15]

Specific Disease Summary: Charcot-Marie-Tooth disease, dominant intermediate B
OMIM report

[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB](https://omim.org/entry/606482)

Human gene(s) implicated

[DYNAMIN 2; DNM2](https://omim.org/entry/602378)

Symptoms and phenotype
Genetics

A map of mutations of DNM2 implicated in CNM1 and in Charcot-Marie-Tooth (CMT) disease is shown in Bohm et al., 2012 (pubmed:22396310). Mutations of CMT most frequently affect the PH domain, with one example in the MID region; there is no overlap between the two diseases in terms of nucleotides affected.

Forms of dominant intermediate Charcot-Marie-Tooth (CMT) disease and axonal CMT that map to chromosome 19p, designated CMTDIB and CMT2M, respectively, can be caused by heterozygous mutation in the gene encoding dynamin-2 (DNM2). [from MIM:606482; 2019.02.20]

Cellular phenotype and pathology
Molecular information

Dynamin 2 is a microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (by similarity); in vesicular trafficking processes, in particular endocytosis; and in cytokinesis.

[Gene Cards, DNM2; 2019.02.20]

DNM2 is a ubiquitously expressed large GTPase involved in clathrin-dependent and-independent endocytosis and intracellular membrane trafficking. DNM2 interacts tightly with actin and microtubule networks and may have a role in centrosome function (summary by Durieux et al., 2010; pubmed:20858595). [from MIM:602378; 2015.12.17]

External links
Disease synonyms
Charcot-Marie-Tooth disease, axonal type 2M
CMT2M
CMTDIB
DI-CMTB
dominant intermediate Charcot-Marie-Tooth neuropathy type B
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
Symbol / Name
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 3 human to 1 Drosophila; additional orthologous human genes are DNM1 and DNM3.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human DNM1, DNM2, and DNM3 (1 Drosphila to 3 human). Dmel\shi shares 62-66% identity and 73-78% similarity with the human genes.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (14 groups)
      protein-protein
      Interacting group
      Assay
      References
      anti bait coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, anti tag western blot
      pull down, western blot, autoradiography, far western blotting, molecular weight estimation by staining, anti bait coimmunoprecipitation, cosedimentation, edman degradation
      anti tag coimmunoprecipitation, peptide massfingerprinting, pull down, autoradiography
      pull down, western blot, anti bait coimmunoprecipitation
      anti bait coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, peptide massfingerprinting
      anti bait coimmunoprecipitation, western blot, pull down, two hybrid
      anti tag coimmunoprecipitation, peptide massfingerprinting
      anti tag coimmunoprecipitation, peptide massfingerprinting
      pull down, western blot, Identification by mass spectrometry
      cosedimentation, western blot
      pull down, western blot
      cosedimentation, western blot
      Alleles Reported to Model Human Disease (Disease Ontology) (11 alleles)
      Models Based on Experimental Evidence ( 2 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 7 )
      Models Based on Experimental Evidence ( 3 )
      Modifiers Based on Experimental Evidence ( 0 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      ethyl methanesulfonate
      loss of function allele
      X ray
      loss of function allele
      ethyl methanesulfonate
      ethyl methanesulfonate
      loss of function allele
      ethyl methanesulfonate
      References (5)